Pharmaceutical Industry Information Portal

HomeManufacturers News

Manufacturers News

Efficacy of Areplivir (favipiravir) in the treatment of COVID-19 discussed at the 16th Russian Congress of Internal Medicine

On the first day of the 16th Russian Congress of Internal Medicine, Promomed Group organized a satellite symposium «Always on the same side against...

Binnopharm Group and Sartorius partner to manufacture biotechnological medicines and vaccines against COVID-19

Binnopharm Group (part of Sistema) and Sartorius, one of the leading global manufacturers of equipment for the biopharmaceutical industry, have signed a strategic partnership...

The first Russian injectable drug for treatment of COVID-19 is ap-proved

The first Russian direct-acting intravenous antiviral drug Areplivir® (favipiravir) received marketing authorization certificate and its supply to hospitals in all regions will start by...

R-Pharm presented results of phase III global research program for rheumatoid arthritis drug, novel IL-6 inhibitor Olokizumab

In the framework of the annual ACR Convergence 2021, R-Pharm Group presented successful results of olokizumab in two randomized clinical trials of phase III...

Expert RA assigns an expected ruA credit rating to Binnopharm Group’s planned bond issue

Binnopharm Group, a holding company that combines Sistema’s pharmaceutical assets, announces that the Expert RA rating agency has assigned an expected ruA credit rating...

Russian Health Ministry recommends RA drug olokizumab for patients with COVID-19 of any severity

The Ministry of Health of the Russian Federation has issued the 12th version of the Temporary guidelines for the prevention, diagnosis and treatment of...
spot_img

Expert Articles

spot_img